Header Logo

Connection

Xiaoduo Fan to Middle Aged

This is a "connection" page, showing publications Xiaoduo Fan has written about Middle Aged.
Connection Strength

0.261
  1. Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology (Berl). 2019 Jun; 236(6):1949-1957.
    View in: PubMed
    Score: 0.046
  2. Wu C, Chiang M, Harrington A, Kim S, Ziedonis D, Fan X. Racial disparity in mental disorder diagnosis and treatment between non-hispanic White and Asian American patients in a general hospital. Asian J Psychiatr. 2018 Apr; 34:78-83.
    View in: PubMed
    Score: 0.044
  3. Rajan S, Zalpuri I, Harrington A, Cimpeanu C, Song X, Fan X. Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia. Int Clin Psychopharmacol. 2016 Jan; 31(1):51-6.
    View in: PubMed
    Score: 0.037
  4. Sheng J, Li C, Wang J, Chiang C, Harrington A, Yi Z, Liu D, Fan X. Phenotypic characteristics in metabolically healthy but obese patients with schizophrenia. Psychiatry Res. 2014 Dec 15; 220(1-2):71-5.
    View in: PubMed
    Score: 0.034
  5. Fan X, Liu E, Freudenreich O, Copeland P, Hayden D, Ghebremichael M, Cohen B, Ongur D, Goff DC, Henderson DC. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol. 2013 Apr; 33(2):226-30.
    View in: PubMed
    Score: 0.031
  6. Li J, Li X, Liu E, Copeland P, Freudenreich O, Goff DC, Henderson DC, Song X, Fan X. No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia. Schizophr Res. 2013 May; 146(1-3):40-5.
    View in: PubMed
    Score: 0.031
  7. Li H, Guo W, Liu F, Chen J, Su Q, Zhang Z, Fan X, Zhao J. Enhanced baseline activity in the left ventromedial putamen predicts individual treatment response in drug-naive, first-episode schizophrenia: Results from two independent study samples. EBioMedicine. 2019 Aug; 46:248-255.
    View in: PubMed
    Score: 0.012
  8. Du J, Quan M, Zhuang W, Zhong N, Jiang H, Kennedy DN, Harrington A, Ziedonis D, Fan X, Zhao M. Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behav Brain Res. 2015 Aug 01; 289:78-83.
    View in: PubMed
    Score: 0.009
  9. Vincenzi B, Stock S, Borba CP, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC. A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism. Schizophr Res. 2014 Nov; 159(2-3):395-403.
    View in: PubMed
    Score: 0.009
  10. Ding M, Song X, Zhao J, Gao J, Li X, Yang G, Wang X, Harrington A, Fan X, Lv L. Activation of Th17 cells in drug na?ve, first episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 03; 51:78-82.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.